Die wichtigsten Publikationen

Fu Z., Regan K., Zhang L., Muders MH, Thibodeau SN, French A, Wu Y, Kaufmann SH, Lingle WL, Chen J, Tindall DJ.(2009) Deficiencies in Chfr and Mlh1 synergistically enhance tumor susceptibilty in mice. J Clin Invest. 119(9):2714-24.

Muders MH, Zhang H, Wang E, Tindall DJ, Datta K. (2009) Vascular endothelial growth factor-C protects prostate cancer cells from oxidative stress by the activation of mammalian target of rapamycin complex-2 and Akt-1. Cancer Res. 69(15):6042-48

Muders MH, Vohra PK, Dutta SK, Wang E, Ikeda Y, Wang L, Udugamasooriya DG, Memic A, Rupasinge CN, Baretton GB, Aust DE, Langer S, Datta K, Simons M, Spaller MR, Mukhopadhyay D (2009), Targeting GIPC/Synectin in pancreatic cancer inhibits tumor growth. Clin Cancer Res 15(12): 4095-103

Zhang H, Muders MH, Li J, Rindaldo F, Tindall DJ, Datta K (2008). Loss of NKX3.1 favors vascular endothelial growth factor-C expression in prostata cancer. Cancer Res. 68 (21):8770-8.

Rinaldo F, Li J, Wang E, Muders M, Datta K. (2007) RalA regulates vascular endothelial growth factor-C (VEGF-C) synthesis in prostate cancer cells during androgen ablation. Oncogene 26(12):1731-8.

Muders MH, Dutta SK, Wang L, Lau JS, Bhattacharya R, Smyrk TC, Chari ST, Datta K, Mukhopadhyay D. (2006) Expression and regulatory role of GAIP-interacting protein GIPC in pancreatic adenocarcinoma. Cancer Res 66(21): 10264-8.

Klicken Sie hier, um alle Publikationen in PubMed zu sehen.